title: Diagnostic accuracy of calretinin for malignant mesothelioma in serous effusions: a meta-analysis.
abstract: Numerous studies have investigated the utility of calretinin in differentiating malignant mesothelioma (MM) from metastatic carcinoma (MC) in serous effusions. However, the results remain controversial. The aim of this study is to determine the overall accuracy of calretinin in serous effusions for MM through a meta-analysis of published studies. Publications addressing the accuracy of calretinin in the diagnosis of MM were selected from the Medline (Ovid), PubMed, the Cochrane Library Database and the Web of Science. Data from selected studies were pooled to yield summary sensitivity, specificity, positive and negative likelihood ratio (LR), diagnostic odds ratio (DOR), and receiver operating characteristic (SROC) curve. Statistical analysis was performed by Meta-Disc 1.4 and STATA 12.0 softwares. 18 studies met the inclusion criteria and the summary estimating for calretinin in the diagnosis of MM were: sensitivity 0.91 (95%CI: 0.87-0.94), specificity 0.96 (95%CI: 0.95-0.96), positive likelihood ratio (PLR) 14.42 (95%CI: 7.92-26.26), negative likelihood ratio (NLR) 0.1 (95%CI: 0.05-0.2) and diagnostic odds ratio 163.03 (95%CI: 54.62-486.63). The SROC curve indicated that the maximum joint sensitivity and specificity (Q-value) was 0.92; the area under the curve was 0.97. Our findings suggest that calretinin may be a useful diagnostic tool for confirming MM in serous effusions.
authors.affiliation: 1] Department of Respiratory Medicine,West China Hospital of Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, China [2] Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Sichuan University, No.1 4th Keyuan Road, Chengdu, Sichuan, China.
authors.forename: Diandian
authors.initials: D
authors.lastname: Li
authors.affiliation: 1] Department of Respiratory Medicine,West China Hospital of Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, China [2] Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Sichuan University, No.1 4th Keyuan Road, Chengdu, Sichuan, China.
authors.forename: Bo
authors.initials: B
authors.lastname: Wang
authors.affiliation: 1] Department of Respiratory Medicine,West China Hospital of Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, China [2] Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Sichuan University, No.1 4th Keyuan Road, Chengdu, Sichuan, China.
authors.forename: Hongyu
authors.initials: H
authors.lastname: Long
authors.affiliation: 1] Department of Respiratory Medicine,West China Hospital of Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, China [2] Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Sichuan University, No.1 4th Keyuan Road, Chengdu, Sichuan, China.
authors.forename: Fuqiang
authors.initials: F
authors.lastname: Wen
mesh_terms: D014408:Biomarkers, Tumor; D064026:Calbindins / Q000378:metabolism*; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000378:metabolism*; D008654:Mesothelioma / Q000175:diagnosis* / Q000378:metabolism*; D000086002:Mesothelioma, Malignant; D016066:Pleural Effusion, Malignant / Q000378:metabolism*; D017594:Publication Bias; D012372:ROC Curve; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
chemical_list: D014408:Biomarkers, Tumor; D064026:Calbindins
references.citation: Am J Crit Care. 2011 Mar;20(2):119-27; quiz 128
references.pmid: 21362716
references.citation: Cytopathology. 2011 Feb;22(1):5-21
references.pmid: 21114695
references.citation: Diagn Cytopathol. 2010 Dec;38(12):874-9
references.pmid: 20049969
references.citation: Int J Cardiol. 2010 Apr 15;140(2):138-44
references.pmid: 19592119
references.citation: Diagn Cytopathol. 2010 Apr;38(4):264-9
references.pmid: 20146302
references.citation: Diagn Cytopathol. 2010 Jan;38(1):9-14
references.pmid: 19626629
references.citation: Int J Clin Pract. 2009 Oct;63(10):1426-34
references.pmid: 19769699
references.citation: Diagn Cytopathol. 2009 May;37(5):324-32
references.pmid: 19191294
references.citation: Cancer. 2000 Feb 25;90(1):55-60
references.pmid: 10692217
references.citation: Tumour Biol. 2013 Dec;34(6):3667-74
references.pmid: 23807679
references.citation: Clin Chem Lab Med. 2014 Feb;52(2):253-8
references.pmid: 24096441
references.citation: Cancer Cytopathol. 2014 Apr;122(4):299-306
references.pmid: 24421209
references.citation: J Health Serv Res Policy. 2008 Oct;13 Suppl 3:57-63
references.pmid: 18806193
references.citation: Cancer. 2000 Jun 25;90(3):194-200
references.pmid: 10896333
references.citation: Cancer. 2001 Feb 25;93(1):68-72
references.pmid: 11241268
references.citation: Am J Surg Pathol. 2001 Nov;25(11):1405-12
references.pmid: 11684957
references.citation: Appl Immunohistochem Mol Morphol. 2002 Jun;10(2):178-82
references.pmid: 12051638
references.citation: J Clin Epidemiol. 2003 Nov;56(11):1129-35
references.pmid: 14615004
references.citation: BMC Med Res Methodol. 2003 Nov 10;3:25
references.pmid: 14606960
references.citation: J Cell Biol. 1987 Sep;105(3):1343-53
references.pmid: 3654755
references.citation: Stat Med. 1993 Jul 30;12(14):1293-316
references.pmid: 8210827
references.citation: Diagn Cytopathol. 1999 Mar;20(3):125-30
references.pmid: 10086235
references.citation: Diagn Cytopathol. 2005 Mar;32(3):151-5
references.pmid: 15690338
references.citation: J Clin Epidemiol. 2005 Sep;58(9):882-93
references.pmid: 16085191
references.citation: Mod Pathol. 2006 Apr;19(4):514-23
references.pmid: 16554731
references.citation: Pathology. 2011 Jun;43(4):313-7
references.pmid: 21532523
references.citation: Diagn Cytopathol. 2009 Apr;37(4):258-61
references.pmid: 19217030
references.citation: Pol J Pathol. 2011;62(2):95-100
references.pmid: 21866465
references.citation: Diagn Cytopathol. 2011 Dec;39(12):900-8
references.pmid: 20836004
references.citation: Acta Cytol. 2012;56(5):527-32
references.pmid: 23075894
references.citation: Lung. 2013 Apr;191(2):165-75
references.pmid: 23315213
references.citation: PLoS One. 2013;8(9):e73278
references.pmid: 24023850
references.citation: Cytopathology. 2008 Aug;19(4):218-23
references.pmid: 17916095
references.citation: Cancer. 2008 Feb 25;114(1):49-56
references.pmid: 18098206
references.citation: Arch Pathol Lab Med. 2008 Jan;132(1):23-8
references.pmid: 18181669
references.citation: Leg Med (Tokyo). 2008 Jan;10(1):20-5
references.pmid: 17702624
references.citation: Diagn Cytopathol. 2007 Jun;35(6):342-7
references.pmid: 17497664
references.citation: Diagn Cytopathol. 2007 Jun;35(6):370-5
references.pmid: 17497661
references.citation: BMC Med Res Methodol. 2006;6:31
references.pmid: 16836745
references.citation: Diagn Cytopathol. 2006 Dec;34(12):801-6
references.pmid: 17115439
references.citation: Mod Pathol. 2007 Feb;20(2):248-55
references.pmid: 17361207